Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
04/2001
04/04/2001EP1007949A4 Multiple assays of cell specimens
04/04/2001EP0850415B1 Determination of sodium sulfide and sulfidity in green liquors and smelt solutions
04/04/2001EP0756638B1 Means for treating disorders in the blood coagulation cascade
04/04/2001EP0741734B1 Phenylboronic acid complexes
04/04/2001EP0576667B1 Test kit and method for the determination of pesticides
04/04/2001CN2426154Y Microcentrifuge tube
04/04/2001CN2426153Y High-efficiency multi-disc bacteriostasis ring automatic measuring analysis instrument
04/04/2001CN1290349A Pharmaceutical grade ginkgo biloba
04/04/2001CN1290348A Analytic plate and method
04/04/2001CN1290347A Gin process control
04/04/2001CN1290346A Subsampling fiber testing system
04/04/2001CN1290345A Fiber micronaire testing system
04/04/2001CN1290344A High volume fiber testing system
04/04/2001CN1290306A High throughput assay system
04/04/2001CN1290195A Capillary active test element having an intermediate layer situated between the support and the covering
04/04/2001CN1290161A Nuclear receptor ligands and ligand binding domains
04/04/2001CN1289927A Method and equipment for examining internal surface of railway tanker
04/04/2001CN1289926A Process for preparing human placenta lactogen as diagnostic reagent
04/04/2001CN1289925A Process for preparing beta 1 glucopntein reagent to diagnose pregnancy specificity
04/04/2001CN1289924A II-type collegen enzyme-linked immunoassay analysis
04/04/2001CN1063957C Method for preparing fagopyrum cymosum preparation
04/04/2001CA2286414A1 Non-separation heterogenous assay for biological substance
04/03/2001US6212418 Methods, kits, electrodes and compositions for assessing the level of an analyte of interest in fluid samples
04/03/2001US6212417 Biosensor
04/03/2001US6211955 Imaging and analyzing parameters of small moving objects such as cells
04/03/2001US6211953 Vessel for imaging fluorescent particles
04/03/2001US6211952 Method and apparatus for inspecting glass containers for checks
04/03/2001US6211359 Triaza-cryptand and method of determining an alkali ion
04/03/2001US6211352 Method for the diagnosis and treatment of glutamic acid decarboxylase autoantigen associated diseases
04/03/2001US6211344 Purifying the starting plasma by immunoadsorption with monoclonal and polyclonal antibodies against factor v to prepare factor v-deficient plasma capable of detecting inactivatable factor v from starting plasma using antibodies
04/03/2001US6211336 Ataxia-telangiectasia gene
04/03/2001US6211334 Cell-cycle regulatory proteins, and uses related thereto
04/03/2001US6211244 Aromatic amines for complexing calcium
04/03/2001US6211164 Sensitization of tumor cells
04/03/2001US6211161 UDP-N-acetylmuramoyl-l-alanine:D-glutamate ligase (MURD) of staphylococcus aureus
04/03/2001US6211146 60A protein-induced morphogenesis
04/03/2001US6210978 Method and device for the detection of analyte in a fluid test sample
04/03/2001US6210977 Apparatus for monitoring biocompatible particles; for the amplification of mechanical anchoring of biocompatible particles on the surfaces of sensors and the amplification of signal transmission from patricles in solution
04/03/2001US6210976 Measuring level of lipid, other than lysophospholipid, cardiac marker in test sample from human; determining if level of cardiac marker measured in test sample correlates with condition which causes heart failure in human
04/03/2001US6210975 Process for determining a bindable analyte via immune precipitation and reagent therefor
04/03/2001US6210971 Contacting fluid test sample with reagent comprising cupric ions, hydroperoxide, citrate and oxidizable dye which provides colored response in presence of oxygen free radicals and pseudoperoxide and determining concentration of ceratinine
04/03/2001US6210970 Method of diagnosing or categorizing disorders from biochemical profiles
04/03/2001US6210969 Lytic reagents for automatically determining leukocyte subpopulations in blood, selectively lysing red blood cells
04/03/2001US6210968 DNA molecules encoding pgp3 protein from Chlamydia trachomatis
04/03/2001US6210962 Nucleotide and peptide sequences of an isolate of the hepatitis C virus, diagnostic and therapeutic applications thereof
04/03/2001US6210944 Phosphoribosyl transferase from Staphylococcus aureus
04/03/2001US6210917 By treating methylthioadenosine phosphorylase deficient cells with adenine synthesis inhibitor to deplete the target cells of adenosine 5'-triphosphate
04/03/2001US6210916 Mixture of enzyme involved in cell cycle control, serine-containing substrate of the enzyme, and gamma-phosphate labeled adenosine triphosphate; for screening agonists and antagonists of enzyme
04/03/2001US6210914 Method to identify proteins which bind to integrin regulatory proteins
04/03/2001US6210913 Modulation of integrin-mediated signal transduction
04/03/2001US6210912 Method for examining chronic rejection reactions following organ transplantation and method for determining urine components
04/03/2001US6210911 Multistep prodcess by determining whether microorganism is escherichia coli, culturing in sorbitol-containing medium to determine fermentation, then measuring growth rate-related value of culture including ar1 phage and comparing to control
04/03/2001US6210910 Inserting cells into microwells on individual fiber strands, optically coupling detector to strands, contacting with sample, and measuring response
04/03/2001US6210909 Liquid specimen container and attachable testing modules
04/03/2001US6210908 Solid support for use in immunoassays, especially against human immunodeficiency virus; a cyclic peptide linked through a 3-sulfide-succinimide moiety to a protein, enzyme, or antibody
04/03/2001US6210906 Contacting sample with monoclonal antibody or fragment against lipoprotein(a) which has been immobilized on a solid support, forming immunocomplexes, and determining amount bound; diagnosis of cardiovascular disorders
04/03/2001US6210904 Diagnosing for risk of thromocytopenia by detecting absence of association of monoclonal antibody with glycoprotein iib/iia receptor:glycoprotein iib/iia receptor antagonist complex
04/03/2001US6210903 Amino acid sequence which is optionally modified and biotinylated
04/03/2001US6210902 Using two immunoassays to measure two different type 1 collagen breakdown products of defined amino acid sequence in sample and forming an index representing the difference in results; diagnosis of bone disorders such as osteoporosis
04/03/2001US6210901 Modified hepatitis c virus amino acid sequence which binds to an antibody; for screening blood samples
04/03/2001US6210900 Multistep process for preparing similar libraries of the lead structure
04/03/2001US6210899 Use of a BMP protein receptor complex for screening bone metabolism actives and cells co-transfected with a type II BMP receptor and type I BMP receptor
04/03/2001US6210898 Using strip of porous material which transports sample liquid by capillary action to several unique capture reagents immobilized in discrete spaced apart spots, then determining binding of analyte at the spots
04/03/2001US6210895 Comparing concentration of heme oxygenase-1 or its nucleotide sequence in body fluid or non-neural tissue to control; reduction indicates alzheimer's disease, age-associated cognitive decline, creutzfeld-jacob disease, or other disease
04/03/2001US6210894 Method and apparatus for conducting an array of chemical reactions on a support surface
04/03/2001US6210889 Method for enrichment of fetal cells from maternal blood and use of same in determination of fetal sex and detection of chromosomal abnormalities
04/03/2001US6210885 Modifying double stranded DNA to enhance separations by matched ion polynucleotide chromatography
04/03/2001US6210878 Screening for presence of breast cancer cells in sample from human patient by contacting with hybridization probe which binds selectively to region of chromosome 20 having altered copy number, then detecting
04/03/2001US6210877 Prediction of coronary artery disease
04/03/2001US6210874 Synthetic peptides and mixtures thereof for detecting HIV antibodies
04/03/2001US6210873 Methods and compositions for the priming of specific cytotoxic T-lymphocyte response
04/03/2001US6210682 Immunization against rotavirus infection or rotavirus disease by administering to a subject a peptide nsp4 114-135, a peptide nsp4 120-147, or a toxoid thereof are disclosed.
04/03/2001US6210676 Compositions and methods using the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein C (OspC) for the diagnosis and prevention of lyme disease
04/03/2001US6210675 Post-transfusional non-a non-b hepatitis viral polypeptide
04/03/2001US6210674 GreA from Staphylococcus aureus
04/03/2001US6210670 Cross-reacting monoclonal antibodies specific for E-selectin and P-selectin
04/03/2001US6210661 IL-4 receptor for the therapy, prophylaxis and diagnosis of allergic, viral, and bacterial diseases and of fungal infections
04/03/2001US6210574 System for separation of nucleated fetal erythrocytes from maternal blood samples
04/03/2001US6210559 Use of 13C NMR spectroscopy to produce optimum fischer-tropsch diesel fuels and blend stocks
04/03/2001US6210551 Composite membrane sensor
04/03/2001US6209385 Method and system for determining air/fuel ratio of an engine's combustion process from its exhaust emissions
04/03/2001US6209384 Solenoid operated molten metal probe
04/03/2001CA2196795C Method for diagnosing a predisposition for breast and ovarian cancer
04/03/2001CA2163755C Dna encoding prostaglandin receptor ep1
04/03/2001CA2153180C Interleukin 4 signal transducers and binding assays
04/03/2001CA2118043C Immortalized human cell lines containing exogenous cytochrome p450 genes
04/03/2001CA2021892C Monitoring performance of a treating agent added to a body of water
03/2001
03/30/2001WO2003044525A1 Targeting cells having mad2 mutation for treatment and/or prevention of disease
03/30/2001WO2003042411A2 Use of mutations of mec-1 and its related genes in the identification of compounds for treatment of disease
03/30/2001WO2002090588A1 Interfering with telomere maintenance in treatment of diseases
03/30/2001CA2385808A1 Targeting cells having mad2 mutation for treatment and/or prevention of disease
03/30/2001CA2384139A1 Interfering with telomere maintenance in treatment of diseases
03/30/2001CA2380624A1 Mutation of mec-1 related genes in the treatment of disease
03/30/2001CA2283538A1 New hev antigenic peptide and methods
03/29/2001WO2001022741A2 Medical applications of orthogonal polarization spectral imaging
03/29/2001WO2001022093A1 Method for monitoring treatment with a parathyroid hormone
03/29/2001WO2001022092A2 Method to identify compounds which modulate fra-1 expression fils
03/29/2001WO2001022091A2 Method for determining the fertility of mammals, especially of humans
03/29/2001WO2001022090A1 Method for identifying compounds useful in the therapy of bone disorders
03/29/2001WO2001022089A1 HYBRIDIZATION SELF-REcOGNITION TYPE PROBE